Stanford broadens amplification licence:
This article was originally published in Clinica
Executive Summary
Stanford University (US) has broadened the licence to its patent rights covering transcription-based amplification technology. An exclusive licence with Gen-Probe has been converted to a co-exclusive agreement, enabling both Gen-Probe and Organon Teknika to practise under the relevant patents. The companies will also be able to license versions of the technology, which is being used to develop new-generation tests for the diagnosis of infectious diseases, cancer and genetic disorders.